Evidence map›Paper›PMID 31624292›Full record

ArticleScientific reports2019

Strategies to reduce genetic mosaicism following CRISPR-mediated genome edition in bovine embryos.

I Lamas-Toranzo, B Galiano-Cogolludo, F Cornudella-Ardiaca, J Cobos-Figueroa, O Ousinde, P Bermejo-Álvarez

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. CRISPR-Cas9 in the Tailoring of Genetically Engineered Animals.Current issues in molecular biology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Frontiers in immunology · 2024
    Article
  18. Ablation ofPNAS nexus · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

I Lamas-ToranzoAnimal Reproduction Department, INIA, Madrid, Spain.ORCID http://orcid.org/0000-0002-7790-2649
B Galiano-CogolludoAnimal Reproduction Department, INIA, Madrid, Spain.
F Cornudella-ArdiacaAnimal Reproduction Department, INIA, Madrid, Spain.
J Cobos-FigueroaAnimal Reproduction Department, INIA, Madrid, Spain.
O OusindeAnimal Reproduction Department, INIA, Madrid, Spain.
P Bermejo-ÁlvarezAnimal Reproduction Department, INIA, Madrid, Spain. borrillobermejo@hotmail.com.ORCID http://orcid.org/0000-0001-9907-2626

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic mosaicism is the presence of more than two alleles on an individual and it is commonly observed following CRISPR microinjection of zygotes. This phenomenon appears when DNA replication precedes CRISPR-mediated genome edition and it is undesirable because it reduces greatly the odds for direct KO generation by randomly generated indels. In this study, we have developed alternative protocols to reduce mosaicism rates following CRISPR-mediated genome edition in bovine. In a preliminary study we observed by EdU incorporation that DNA replication has already occurred at the conventional microinjection time (20 hpi). Aiming to reduce mosaicism appearance, we have developed three alternative microinjection protocols: early zygote microinjection (10 hpi RNA) or oocyte microinjection before fertilization with either RNA or Ribonucleoprotein delivery (0 hpi RNA or 0 hpi RNP). All three alternative microinjection protocols resulted in similar blastocyst and genome edition rates compared to the conventional 20 hpi group, whereas mosaicism rates were significantly reduced in all early delivery groups (~10-30% of edited embryos being mosaic depending on the loci) compared to conventional 20 hpi microinjection (100% mosaicism rate). These strategies constitute an efficient way to reduce the number of indels, increasing the odds for direct KO generation.

Indexed as

MosaicismAnimalsBlastocystCattleCRISPR-Cas SystemsDNA ReplicationFemaleGene EditingGene Knockout TechniquesGenotyping TechniquesINDEL MutationMicroinjectionsModels, AnimalOocytesRibonucleoproteinsRNA, Guide, CRISPR-Cas SystemsRibonucleoproteinsRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID31624292
PMCPMC6797768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.